Soybean Extract
Product Description
Product nomen:Soybean Extract
Categoria:Plant Excerpta
Effective components:Isoflavones
Specificatio product:10.0%~ 90.0%
Analysis:HPLC
Qualitas Imperium:in domo
Proferre:C15H10O2
Pondus hypotheticum:222.24
Aspectus:Pulvis levis flavo cum odore proprio.
Lepidium sativum:Transit omnia criteria probat
Product Function:Soy Isoflavones Extract auxilium menopausae syndrome mulieribus levandis; ne cancer et cancer prostat, cura et ne cancer prostat, inferior cholesterolum et morbus cordis periculum minuere; effectum esse sanum stomachum et lienem et systema nervum tuere; cholesterin crassitudinem in corpore humano minuere, morbum cardiovascularem praevenire et sanare.
ReponoTene in loco frigido et sicco, bene clauso, ab humore vel sole directo.
PECULIUM Volumen:Copia materiae sufficiens et stabili copia alvei rudis materiae.
Testimonium Analysis
Product nomen | Soybean Extract | Botanical Source | Glycine Max L |
Batch NO. | RW-SE20210410 | Batch Quantity | 1100 kgs |
OPIFICIUM Date | Apr. 10. 2021 | Expirata Date | Apr. 15. 2021 |
Solvendo Residuum | Aquae & Ethanol | Part Used | Semen |
ITEMS | SPECIFICATION | VIA | Test effectus |
Physica & Chemical Data | |||
Color | Lumen flavum | Organoleptic | secundum quid |
Ordour | Proprium | Organoleptic | secundum quid |
Aspectus | Pulchra pulveris | Organoleptic | secundum quid |
Analytical Quality | |||
Lepidium sativum | Sample RS ad idem | HPTLC | Identical |
Totalis Isoflavones | ≥10.0~90.0% | HPLC | secundum quid |
Damnum in Siccatio | 5.0% Max. | Eur.Ph.7.0 [2.5.12] | secundum quid |
Summa Cinerum | 5.0% Max. | Eur.Ph.7.0 [2.4.16] | secundum quid |
Sieve | XCV% transiet LXXX reticulum | USP36<786> | Conformare |
mole Density | 40~60 g/100ml | Eur.Ph.7.0 [2.9.34] | 54 g/100ml |
Solvendo Residuum | Occurrit Eur.Ph.7.0<5.4> | Eur.Ph.7.0 <2.4.24> | secundum quid |
Pesticides Residue | Occursum USP Requirements | USP36 <561> | secundum quid |
Metalla gravis | |||
Total Metals | 10ppm Max. | Eur.Ph.7.0 <2.2.58> ICP-MS | secundum quid |
Duc (Pb) | 2.0ppm Max. | Eur.Ph.7.0 <2.2.58> ICP-MS | secundum quid |
Arsenicum (As) | 2.0ppm Max. | Eur.Ph.7.0 <2.2.58> ICP-MS | secundum quid |
Cadmium (Cd) | 1.0ppm Max. | Eur.Ph.7.0 <2.2.58> ICP-MS | secundum quid |
Mercurius (Hg) | 1.0ppm Max. | Eur.Ph.7.0 <2.2.58> ICP-MS | secundum quid |
Microbe Tests | |||
Totalis comitis Plate | NMT 1000cfu/g | USP <2021> | secundum quid |
Totalis fermentum & Molde | NMT 100cfu/g | USP <2021> | secundum quid |
E.Coli | Negative | USP <2021> | Negative |
Salmonella | Negative | USP <2021> | Negative |
Stipare&Storage | Referta in charta-tympana et duo intus loculos plasticos. | ||
NW: 25kgs | |||
Condite in vase bene clauso ab humore, luce, oxygenio. | |||
Vita fasciae | 24 menses sub conditionibus supra et in originali packaging. |
Analyticum: Dang Wang
Repressum a: Lei Li
Probatus: Yang Zhang
Product Function
Soya Isoflavone Extract usus in syndrome menopausarum mulierum levandis; ne cancer et cancer prostat, cura et ne cancer prostat, inferior cholesterolum et morbus cordis periculum minuere; effectum esse sanum stomachum et lienem et systema nervum tuere; cholesterin crassitudinem in corpore humano minuere, morbum cardiovascularem praevenire et sanare.
Applicationem Soybean extract
1. SOY isoflavones impedire cardiovasculares morbos, anti-thrombosin, eventum arteriosclerosi morare, reducere sanguinem totalem cholesteroli concentrationis, et incidentiam morbi cordis minuere;
2. SOY isoflavones prohibent osteoporosos, soy isoflavones habent effectus estrogenicos sine parte effectus utendi estrogen. Receptatores estrogenum in cellulis osseis ligant, actionem cellularum ossearum roborant et productionem et secretionem matricis ossis et processum mineralizationis ossis fovere possunt, ne fiat osteoporosis;
3. SOY isoflavones renium morbum demisso sanguine lipidorum et renium functionem tueri possunt;
4. SOY isoflavones has antioxidant functionem, addita in fucis morandi cutem senescit et artans, ita cutem multam glabram et delicatam efficit.